The FASEB Journal · 2018 · 23 citations · 32 references
Life SciencesCell BiologyMolecular BiologyCell JunctionsCell SignalingSignal TransductionEndothelial DysfunctionG Protein-coupled Receptor SignalingJunctional SignalingProtein Phosphatase SignalingReceptor Tyrosine Kinase SignalingArf Gtpase RegulationEndothelial Cell Tight JunctionsEndothelial Tight JunctionsProtein Tyrosine Phosphatase InhibitorsRas Gtpase SignalingVascular Endothelial JunctionsVe-cadherin Regulation
Vascular endothelial (VE)-cadherin junctional localization is known to play a central role in vascular development, endothelial barrier integrity, and homeostasis. The sarcoma homology domain containing protein tyrosine phosphatase (SHP)2 has been shown to be involved in regulating endothelial barrier function; however, the mechanisms remain largely unknown. In this work SHP2 knockdown in an HUVEC monolayer increased VE-cadherin internalization and endothelial barrier permeability. Loss of SHP2 specifically augmented the GTPase activity of ADP-ribosylation factor (ARF)-1. ARF1 knockdown or inhibition of its guanine nucleotide exchange factors (GEFs) markedly attenuated VE-cadherin internalization and barrier hyperpermeability induced by SHP2 deficiency. SHP2 knockdown increased the total and phosphorylated levels of MET, whose activity was necessary for ARF1 activation and VE-cadherin internalization. Furthermore, constitutive endothelium-specific deletion of Shp2 in mice led to disrupted endothelial cell junctions, massive hemorrhage, and lethality in embryos. Induced and endothelium-specific deletion of Shp2 in adult mice resulted in lung hyperpermeability. Inhibitors for ARF1-GEF or MET used in pregnant mice prevented the vascular leakage in endothelial Shp2-deleted embryos. Together, our findings define a novel role of SHP2 in stabilizing junctional VE-cadherin in the resting endothelial barrier through suppressing MET and ARF1 activation.-Zhang, J., Huang, J., Qi, T., Huang, Y., Lu, Y., Zhan, T., Gong, H., Zhu, Z., Shi, Y., Zhou, J., Yu, L., Zhang, X., Cheng, H., Ke, Y. SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1.
32
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Ying-Nan P. Chen, Matthew J. LaMarche, Ho Man Chan et al. · Nature · 2016 · 929 citations
A protocol for isolation and culture of human umbilical vein endothelial cells
Bruno Baudin, Arnaud Bruneel, Nelly Bosselut et al. · Nature Protocols · 2007 · 524 citations
Fabrizio Orsenigo, Costanza Giampietro, Aldo Ferrari et al. · Nature Communications · 2012 · 462 citations · Full text